This report contains market size and forecasts of Histone Deacetylase (HDAC) Inhibitors in global, including the following market information:
Global Histone Deacetylase (HDAC) Inhibitors Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Histone Deacetylase (HDAC) Inhibitors Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Histone Deacetylase (HDAC) Inhibitors companies in 2020 (%)
The global Histone Deacetylase (HDAC) Inhibitors market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Histone Deacetylase (HDAC) Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Histone Deacetylase (HDAC) Inhibitors Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Histone Deacetylase (HDAC) Inhibitors Market Segment Percentages, By Type, 2020 (%)
Fatty Acid
Hydroxamate
Cyclic Peptide
Benzamide
Global Histone Deacetylase (HDAC) Inhibitors Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Histone Deacetylase (HDAC) Inhibitors Market Segment Percentages, By Application, 2020 (%)
Treatment of Malignant Tumors
Chronic Disease Treatment
Others
Global Histone Deacetylase (HDAC) Inhibitors Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Histone Deacetylase (HDAC) Inhibitors Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Histone Deacetylase (HDAC) Inhibitors revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Histone Deacetylase (HDAC) Inhibitors revenues share in global market, 2020 (%)
Key companies Histone Deacetylase (HDAC) Inhibitors sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Histone Deacetylase (HDAC) Inhibitors sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
4SC
Acetylon Pharmaceuticals
Celleron Therapeutics
Chipscreen Biosciences
Chroma Therapeutics
CrystalGenomics
Curis
MEI Pharma
Mirati Therapeutics
Novartis
Onxeo
Repligen
TetraLogic
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Histone Deacetylase (HDAC) Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Histone Deacetylase (HDAC) Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Histone Deacetylase (HDAC) Inhibitors Overall Market Size
2.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size: 2021 VS 2027
2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Histone Deacetylase (HDAC) Inhibitors Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Histone Deacetylase (HDAC) Inhibitors Players in Global Market
3.2 Top Global Histone Deacetylase (HDAC) Inhibitors Companies Ranked by Revenue
3.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Companies
3.4 Global Histone Deacetylase (HDAC) Inhibitors Sales by Companies
3.5 Global Histone Deacetylase (HDAC) Inhibitors Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Histone Deacetylase (HDAC) Inhibitors Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Histone Deacetylase (HDAC) Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Histone Deacetylase (HDAC) Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Histone Deacetylase (HDAC) Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 Histone Deacetylase (HDAC) Inhibitors Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Histone Deacetylase (HDAC) Inhibitors Market Size Markets, 2021 & 2027
4.1.2 Fatty Acid
4.1.3 Hydroxamate
4.1.4 Cyclic Peptide
4.1.5 Benzamide
4.2 By Type - Global Histone Deacetylase (HDAC) Inhibitors Revenue & Forecasts
4.2.1 By Type - Global Histone Deacetylase (HDAC) Inhibitors Revenue, 2016-2021
4.2.2 By Type - Global Histone Deacetylase (HDAC) Inhibitors Revenue, 2022-2027
4.2.3 By Type - Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share, 2016-2027
4.3 By Type - Global Histone Deacetylase (HDAC) Inhibitors Sales & Forecasts
4.3.1 By Type - Global Histone Deacetylase (HDAC) Inhibitors Sales, 2016-2021
4.3.2 By Type - Global Histone Deacetylase (HDAC) Inhibitors Sales, 2022-2027
4.3.3 By Type - Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share, 2016-2027
4.4 By Type - Global Histone Deacetylase (HDAC) Inhibitors Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Histone Deacetylase (HDAC) Inhibitors Market Size, 2021 & 2027
5.1.2 Treatment of Malignant Tumors
5.1.3 Chronic Disease Treatment
5.1.4 Others
5.2 By Application - Global Histone Deacetylase (HDAC) Inhibitors Revenue & Forecasts
5.2.1 By Application - Global Histone Deacetylase (HDAC) Inhibitors Revenue, 2016-2021
5.2.2 By Application - Global Histone Deacetylase (HDAC) Inhibitors Revenue, 2022-2027
5.2.3 By Application - Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share, 2016-2027
5.3 By Application - Global Histone Deacetylase (HDAC) Inhibitors Sales & Forecasts
5.3.1 By Application - Global Histone Deacetylase (HDAC) Inhibitors Sales, 2016-2021
5.3.2 By Application - Global Histone Deacetylase (HDAC) Inhibitors Sales, 2022-2027
5.3.3 By Application - Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share, 2016-2027
5.4 By Application - Global Histone Deacetylase (HDAC) Inhibitors Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Histone Deacetylase (HDAC) Inhibitors Market Size, 2021 & 2027
6.2 By Region - Global Histone Deacetylase (HDAC) Inhibitors Revenue & Forecasts
6.2.1 By Region - Global Histone Deacetylase (HDAC) Inhibitors Revenue, 2016-2021
6.2.2 By Region - Global Histone Deacetylase (HDAC) Inhibitors Revenue, 2022-2027
6.2.3 By Region - Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share, 2016-2027
6.3 By Region - Global Histone Deacetylase (HDAC) Inhibitors Sales & Forecasts
6.3.1 By Region - Global Histone Deacetylase (HDAC) Inhibitors Sales, 2016-2021
6.3.2 By Region - Global Histone Deacetylase (HDAC) Inhibitors Sales, 2022-2027
6.3.3 By Region - Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Histone Deacetylase (HDAC) Inhibitors Revenue, 2016-2027
6.4.2 By Country - North America Histone Deacetylase (HDAC) Inhibitors Sales, 2016-2027
6.4.3 US Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.4.4 Canada Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.4.5 Mexico Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Histone Deacetylase (HDAC) Inhibitors Revenue, 2016-2027
6.5.2 By Country - Europe Histone Deacetylase (HDAC) Inhibitors Sales, 2016-2027
6.5.3 Germany Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.5.4 France Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.5.5 U.K. Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.5.6 Italy Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.5.7 Russia Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.5.8 Nordic Countries Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.5.9 Benelux Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Histone Deacetylase (HDAC) Inhibitors Revenue, 2016-2027
6.6.2 By Region - Asia Histone Deacetylase (HDAC) Inhibitors Sales, 2016-2027
6.6.3 China Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.6.4 Japan Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.6.5 South Korea Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.6.6 Southeast Asia Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.6.7 India Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Histone Deacetylase (HDAC) Inhibitors Revenue, 2016-2027
6.7.2 By Country - South America Histone Deacetylase (HDAC) Inhibitors Sales, 2016-2027
6.7.3 Brazil Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.7.4 Argentina Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales, 2016-2027
6.8.3 Turkey Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.8.4 Israel Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.8.5 Saudi Arabia Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
6.8.6 UAE Histone Deacetylase (HDAC) Inhibitors Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 4SC
7.1.1 4SC Corporate Summary
7.1.2 4SC Business Overview
7.1.3 4SC Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.1.4 4SC Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.1.5 4SC Key News
7.2 Acetylon Pharmaceuticals
7.2.1 Acetylon Pharmaceuticals Corporate Summary
7.2.2 Acetylon Pharmaceuticals Business Overview
7.2.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.2.4 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.2.5 Acetylon Pharmaceuticals Key News
7.3 Celleron Therapeutics
7.3.1 Celleron Therapeutics Corporate Summary
7.3.2 Celleron Therapeutics Business Overview
7.3.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.3.4 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.3.5 Celleron Therapeutics Key News
7.4 Chipscreen Biosciences
7.4.1 Chipscreen Biosciences Corporate Summary
7.4.2 Chipscreen Biosciences Business Overview
7.4.3 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.4.4 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.4.5 Chipscreen Biosciences Key News
7.5 Chroma Therapeutics
7.5.1 Chroma Therapeutics Corporate Summary
7.5.2 Chroma Therapeutics Business Overview
7.5.3 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.5.4 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.5.5 Chroma Therapeutics Key News
7.6 CrystalGenomics
7.6.1 CrystalGenomics Corporate Summary
7.6.2 CrystalGenomics Business Overview
7.6.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.6.4 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.6.5 CrystalGenomics Key News
7.7 Curis
7.7.1 Curis Corporate Summary
7.7.2 Curis Business Overview
7.7.3 Curis Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.4.4 Curis Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.7.5 Curis Key News
7.8 MEI Pharma
7.8.1 MEI Pharma Corporate Summary
7.8.2 MEI Pharma Business Overview
7.8.3 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.8.4 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.8.5 MEI Pharma Key News
7.9 Mirati Therapeutics
7.9.1 Mirati Therapeutics Corporate Summary
7.9.2 Mirati Therapeutics Business Overview
7.9.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.9.4 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.9.5 Mirati Therapeutics Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.10.4 Novartis Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.10.5 Novartis Key News
7.11 Onxeo
7.11.1 Onxeo Corporate Summary
7.11.2 Onxeo Histone Deacetylase (HDAC) Inhibitors Business Overview
7.11.3 Onxeo Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.11.4 Onxeo Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.11.5 Onxeo Key News
7.12 Repligen
7.12.1 Repligen Corporate Summary
7.12.2 Repligen Histone Deacetylase (HDAC) Inhibitors Business Overview
7.12.3 Repligen Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.12.4 Repligen Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.12.5 Repligen Key News
7.13 TetraLogic
7.13.1 TetraLogic Corporate Summary
7.13.2 TetraLogic Histone Deacetylase (HDAC) Inhibitors Business Overview
7.13.3 TetraLogic Histone Deacetylase (HDAC) Inhibitors Major Product Offerings
7.13.4 TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in Global (2016-2021)
7.13.5 TetraLogic Key News
8 Global Histone Deacetylase (HDAC) Inhibitors Production Capacity, Analysis
8.1 Global Histone Deacetylase (HDAC) Inhibitors Production Capacity, 2016-2027
8.2 Histone Deacetylase (HDAC) Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Histone Deacetylase (HDAC) Inhibitors Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Histone Deacetylase (HDAC) Inhibitors Supply Chain Analysis
10.1 Histone Deacetylase (HDAC) Inhibitors Industry Value Chain
10.2 Histone Deacetylase (HDAC) Inhibitors Upstream Market
10.3 Histone Deacetylase (HDAC) Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Histone Deacetylase (HDAC) Inhibitors Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Histone Deacetylase (HDAC) Inhibitors in Global Market
Table 2. Top Histone Deacetylase (HDAC) Inhibitors Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Companies, 2016-2021
Table 5. Global Histone Deacetylase (HDAC) Inhibitors Sales by Companies, (K MT), 2016-2021
Table 6. Global Histone Deacetylase (HDAC) Inhibitors Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Histone Deacetylase (HDAC) Inhibitors Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Histone Deacetylase (HDAC) Inhibitors Product Type
Table 9. List of Global Tier 1 Histone Deacetylase (HDAC) Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Histone Deacetylase (HDAC) Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
4SC
Acetylon Pharmaceuticals
Celleron Therapeutics
Chipscreen Biosciences
Chroma Therapeutics
CrystalGenomics
Curis
MEI Pharma
Mirati Therapeutics
Novartis
Onxeo
Repligen
TetraLogic